Skip to main content
Equibles

MRM · Medirom Healthcare Technologies Inc. · Metrics

Track MRM — free

Use MRM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.58 +0.01 (+1.03%)
Rebalance outlook locked
Market Cap
$5.85M
Shares
7.90M
Volume · Oct 5 35.23K Avg daily vol (3M) 26.53K

MRM metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.57
Market cap
$5.85M

Price action

20 metrics
Price change (1W)
-22.7%
Price change (30D)
-37.8%
Price change (3M)
-46.5%
Price change (6M)
-49.4%
Price change (YTD)
-70.5%
Price change (1Y)
-71.4%
Trailing year
Price change (5Y)
-93.7%
52-week high
$2.71
52-week low
$0.57
Change from 52-week high
-78.9%
Change from 52-week low
+0.0%
Annualized volatility
67.1%
Annualized volatility (3M)
60.6%
Beta
0.3
RSI (14D)
22.4
Price vs SMA 50
-35.7%
Price vs SMA 200
-52.7%
Avg volume (3M)
26,529
Relative volume
3.1
Average dollar volume
$23,718

Company

3 metrics
Sector
Consumer Cyclical
Industry
Personal Services
Shares outstanding
7.90M

Valuation

12 metrics
P / E (TTM)
21.6
Trailing earnings · reciprocal yield 4.6%
PEG ratio
0.8
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 922.3%
P / book
3.5
reciprocal yield 28.8%
FCF yield
-110.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
4.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-28

Profitability

9 metrics
Gross margin
25.1%
Operating margin
-3.8%
Trailing 12 months
Net margin
0.5%
Gross profit (TTM)
$2.02B
Operating profit (TTM)
−$304.21M
Net income (TTM)
$270,617
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-12.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$118.11

Growth

11 metrics
Revenue growth YoY
+21.5%
Year over year
Net income growth YoY
+28.9%
Revenue (TTM)
$53.94M
Trailing 12 months
EPS growth YoY
+27.7%
Shares change YoY
+13.3%
Year over year · more shares
Revenue CAGR (3Y)
+15.3%
Revenue CAGR (5Y)
+16.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+47.7%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
16.7%
Return on assets
0.5%
Debt / equity
—
Current ratio
0.2
EBITDA (TTM)
$278,252
Free cash flow (TTM)
−$6.47M
Quick ratio
0.2
Interest coverage
-5.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$226,559
Total assets
$55.46M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.00M
Capital expenditures (TTM)
$462,675
R&D (TTM)
—
SG&A (TTM)
$14.83M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
8
13F filer change QoQ
+3
Institutional ownership
2.2%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
21 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1819704 CUSIP 58510H103 Visit website Investor relations